探索治疗糖尿病勃起功能障碍的You-gui药丸:数据挖掘分析,网络药理学和体外实验
Jiaqi Chen1,2, Yanan Gao1,2, Yanqiu Zhang1
1Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, 130021, China.
Combinatorial chemistry & high throughput screening
|October 23, 2024
概括
药丸 (YGP) 通过向HIF-1α和TNF-α,有效治疗抗糖尿病勃起功能障碍 (DMED). 主要活性化合物包括奎尔丁,凯姆菲罗尔和β-固醇,通过综合数据挖掘和网络药理方法验证.
科学领域:
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 药丸 (YGP) 是治疗抗糖尿病勃起功能障碍 (DMED) 的传统药物.
- 在YGP中用于DMED治疗的精确活性化合物及其机制尚未完全理解.
- 澄清YGP的活性成分和机制对于其治疗发展至关重要.
研究的目的:
- 确定YGP用于DMED治疗的核心活性成分.
- 阐明YGP对DMED的疗效背后的分子机制.
- 在体外验证YGP的治疗效果和机制.
主要方法:
- 传统中医医学文献的数据挖掘用于DMED治疗.
- 网络药理学,以确定YGP的活性成分和DMED的目标.
- 分子对接以评估活性成分与关键蛋白质的结合亲和力.
- 在实验室验证使用CCEC细胞来分析YGP干预后的目标mRNA表达.
主要成果:
- 网络药理学确定了奎尔丁,凯姆菲罗尔和β-醇作为YGP的核心成分.
- 关键的目标包括HIF-1α,ALB,Bcl-2,INS,IL-1β,IL-6,TNF-α,CASP3和TP53. 这三种类型.
- 分子对接揭示了强烈的结合亲缘关系,特别是与HIF-1α和TNF-α.
- 实验室试验证实了YGP在CCEC细胞中对HIF-1α,ALB,Bcl-2,TNF-α和IL-6mRNA的积极调节.
结论:
- 综合的"数据挖掘 - 网络药理学 - 分子对接 - 实验验证"方法对于研究YGP在DMED中的活性成分和机制是有效的.
- 奎尔赛丁,凯姆菲罗尔和β-固醇被确定为DMED的YGP中的关键活性化合物.
- 通过对特定分子标的调制,YGP证明了DMED的治疗潜力.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
173
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
173
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129
01:24Glucagon-like Receptor Agonists
301
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
301
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
176
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
176
01:15G Protein-coupled Receptors
11.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.4K
01:06Oral Hypoglycemic Agents: Glinides
142
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
142